000 | 01070 a2200289 4500 | ||
---|---|---|---|
005 | 20250513230329.0 | ||
264 | 0 | _c20010301 | |
008 | 200103s 0 0 eng d | ||
022 | _a1434-6621 | ||
024 | 7 |
_a10.1515/CCLM.2000.190 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTolou-Ghamari, Z | |
245 | 0 | 0 |
_aIn vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation. _h[electronic resource] |
260 |
_bClinical chemistry and laboratory medicine _cNov 2000 |
||
300 |
_a1209-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aDrug Monitoring |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aLiver Transplantation |
650 | 0 | 4 |
_aTacrolimus _xtherapeutic use |
700 | 1 | _aWendon, J | |
700 | 1 | _aTredger, J M | |
773 | 0 |
_tClinical chemistry and laboratory medicine _gvol. 38 _gno. 11 _gp. 1209-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1515/CCLM.2000.190 _zAvailable from publisher's website |
999 |
_c11096017 _d11096017 |